| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.217 | 24.924 | 14.629 | 20.645 | 22.991 | 19.529 | 23.047 | 18.221 | 22.130 | 37.748 |
| Total Income - EUR | 24.028 | 26.261 | 15.288 | 20.953 | 23.779 | 19.730 | 23.313 | 18.934 | 22.643 | 37.772 |
| Total Expenses - EUR | 30.320 | 24.188 | 27.223 | 21.222 | 24.269 | 18.074 | 16.326 | 17.325 | 19.532 | 23.962 |
| Gross Profit/Loss - EUR | -6.292 | 2.072 | -11.936 | -269 | -490 | 1.657 | 6.987 | 1.610 | 3.111 | 13.810 |
| Net Profit/Loss - EUR | -6.958 | 1.324 | -12.375 | -890 | -1.180 | 1.236 | 6.295 | 1.063 | 2.613 | 13.440 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Quality Pharmserv S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 402 | 44 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 23.301 | 18.674 | 6.584 | 6.041 | 4.713 | 6.350 | 10.817 | 12.493 | 15.440 | 27.442 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 109 | 0 | 0 | 0 | 0 | 0 | 1.699 | 54 |
| Cash | 23.301 | 18.674 | 6.475 | 6.041 | 4.713 | 6.350 | 10.817 | 12.493 | 13.741 | 27.388 |
| Shareholders Funds | -1.123 | 212 | -12.167 | -12.833 | -13.765 | -12.267 | -5.700 | -4.654 | -2.027 | 11.424 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.869 | 18.625 | 18.865 | 19.048 | 18.581 | 18.676 | 16.547 | 17.197 | 17.518 | 16.145 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Quality Pharmserv S.r.l.